Trials / Completed
CompletedNCT00436540
A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam
A Comparison Between Clobetasol Propionate (Clobex®) Spray and Clobetasol Propionate (Olux®) Foam With Regard to Efficacy, Safety, Preference and Duration of Response in Stable Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the efficacy and safety of clobetasol propionate 0.05% (Clobex®) spray compared to clobetasol propionate 0.05% (Olux®) foam.
Detailed description
Same as above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clobetasol Propionate 0.05% Spray | Apply to affected areas twice daily |
| DRUG | Clobetasol Propionate 0.05% Foam | Apply to affected areas twice daily |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2007-02-19
- Last updated
- 2022-07-29
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00436540. Inclusion in this directory is not an endorsement.